Dear Guests,

International Pharma, Medical Devices and Cosmetics Summit & Fair (IPMS) is planned to take place on 24-25 October, 2018 at ATO Congresium International Convention & Exhibiton Centre, with the support of Ministry of Labor and Social Security and Social Security Institution.

With its main theme being “Transformation Program in Health Industry”, IPMS will be an exclusive platform to reach the global and local targets of Turkish health sector.

The summit will bring together politicians, bureaucrats, academicians, sector representatives and opinion leaders.

Health Transformation Program Phase-2, 2023 Development Plan, Research & Development Incentives, Local Production and Employment will be among the topics at IPMS.

IPMS will contribute to the development of the sector by conveying innovations in the field of pharma and medical devices to related private sector, public enterprises and NGOs.

Prof. Dr. Cevdet Erdöl

Head of Advisory Board, IPMS
Chancellor, University of Health Sciences, Turkey



International Pharma, Medical Devices
and Cosmetics Summit & Fair (IPMS)
is an organization;

  • Encouraging studies related to current problems of domestic and foreign pharmacy, medical device and cosmetics companies,
  • Companies of domestic and foreign pharma, medical devices and cosmetics, hospitals, state institutions and organizations will be sharing their knowledge and experience at their booths,
  • Sharing investment opportunities and technological development studies in pharmacy, medical devices and cosmetics sectors,
  • Bringing together all dynamics of the sector in order to increase the market share of Turkey globally,
  • Discussing the development plans for the health sector with reference to the vision for 2023.

The aim of our summit is to ensure participation of

  • Turkish Ministry of Labor and Social Security,
  • Turkish Ministry of Science, Industry and Technology
  • Turkish Ministry of Health
  • Turkish Ministry of Development,
  • Turkish Ministry of Economy,
  • Turkish Ministry of Finance,
  • Turkish Medicines and Medical Devices Agency (TMMDA),
  • Turkish Social Security Institution (SSI) and its international counterparts,
  • Turkish & foreign state and government representatives,
  • Companies operating in pharmaceutical, medical devices and cosmetics sector,
  • Bureaucrats,
  • Doctors,
  • Academicians,
  • Economists,
  • Foreign investors and their representatives.